D3 Bio is a global biotechnology company focused on the discovery, development, and registration of new medicines in oncology and immunology. The company's discovery and development platforms leverage proprietary clinical insight and biomarker strategies to create novel and clinically meaningful therapies for patients in need.
Leadership & Board
Current Number of Employees25
Current LinkedIn Followers701
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$170M
Total Amount Raised$170M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$108M
Latest Funding Amount$108M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
D3 Bio had 25 employees as of September 14, 2026. The number of employees increased by 1 (4.17%) week-over-week.
25Latest Employee Count
1(4.17%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
D3 Bio had 701 followers as of September 14, 2026. The number of followers increased by 1 (0.14%) week-over-week.
701Latest Followers Count
1(0.14%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.